ArticleJournal of translational medicine2026
PD-1 and TIGIT coexpression enables selective enrichment of clonally expanded tumor-reactive CD8 T cells for melanoma TIL therapy.
Kathleen Ducoin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.